Renaissance Technologies's MRNA Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 568,400 shares of Moderna, Inc. (MRNA) worth $16.76 M, representing 0.03% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in MRNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 1.98 M shares. Largest reduction occurred in Q2 2022, reducing 1.63 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Moderna (MRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Moderna (MRNA) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2019 | +281,800 | New Buy | 281,800 | $14.64 |
| Q3 2019 | -281,800 | Sold Out | 0 | $0.00 |
| Q2 2020 | +315,400 | New Buy | 315,400 | $64.21 |
| Q3 2020 | -315,400 | Sold Out | 0 | $0.00 |
| Q4 2020 | +1.75 M | New Buy | 1.75 M | $104.47 |
| Q1 2021 | -117,195 | Reduce 6.69% | 1.64 M | $130.95 |
| Q2 2021 | +1.55 M | Add 94.95% | 3.19 M | $234.98 |
| Q3 2021 | -1.19 M | Reduce 37.28% | 2 M | $384.86 |
| Q4 2021 | -166,021 | Reduce 8.30% | 1.83 M | $253.98 |
| Q1 2022 | +1.98 M | Add 108.22% | 3.82 M | $172.26 |
| Q2 2022 | -1.63 M | Reduce 42.80% | 2.18 M | $142.85 |
| Q3 2022 | -1.22 M | Reduce 55.91% | 963,041 | $118.25 |
| Q4 2022 | -911,077 | Reduce 94.60% | 51,964 | $0.18 |
| Q1 2023 | +284,748 | Add 547.97% | 336,712 | $0.15 |
| Q2 2023 | -140,013 | Reduce 41.58% | 196,699 | $0.12 |
| Q3 2023 | -196,699 | Sold Out | 0 | $0.00 |
| Q1 2024 | +107,800 | New Buy | 107,800 | $106.56 |
| Q2 2024 | -21,900 | Reduce 20.32% | 85,900 | $118.75 |
| Q3 2024 | +224,400 | Add 261.23% | 310,300 | $66.83 |
| Q4 2024 | +700,458 | Add 225.74% | 1.01 M | $41.58 |
| Q1 2025 | +349,342 | Add 34.56% | 1.36 M | $28.35 |
| Q2 2025 | -356,200 | Reduce 26.19% | 1 M | $27.59 |
| Q3 2025 | -1 M | Sold Out | 0 | $0.00 |
| Q4 2025 | +568,400 | New Buy | 568,400 | $29.49 |
Renaissance Technologies's Moderna Investment FAQs
Renaissance Technologies first purchased Moderna, Inc. (MRNA) in Q2 2019, acquiring 281,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Moderna, Inc. (MRNA) for 24 quarters since Q2 2019.
Renaissance Technologies's largest addition to Moderna, Inc. (MRNA) was in Q1 2022, adding 3,818,180 shares worth $657.72 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 568,400 shares of Moderna, Inc. (MRNA), valued at approximately $16.76 M.
As of the Q4 2025 filing, Moderna, Inc. (MRNA) represents approximately 0.03% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Moderna, Inc. (MRNA) was 3,818,180 shares, as reported at the end of Q1 2022.